VeriMomoligopeptide-17 est-il sûr pendant la grossesse ?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment was identified for 'oligopeptide-17'. No peer‑reviewed reproductive or developmental toxicity data specific to this ingredient were found in PubMed, and peptides of this size used topically are generally polar with low dermal absorption (CosIng / PubChem data lacking specific absorption evidence). Therefore default score is 0 for hazard and mechanism, and exposure is considered negligible for topical cosmetic use.
Pregnancy-safe products containing oligopeptide-17
Related ingredients
Frequently asked questions
- oligopeptide-17 est-il sûr pendant la grossesse ?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment was identified for 'oligopeptide-17'. No peer‑reviewed reproductive or developmental toxicity data specific to this ingredient were found in PubMed, and peptides of this size used topically are generally polar with low dermal absorption (CosIng / PubChem data lacking specific absorption evidence). Therefore default score is 0 for hazard and mechanism, and exposure is considered negligible for topical cosmetic use.
- oligopeptide-17 est-il sûr pendant l'allaitement ?
- No data indicating reproductive or lactation hazards (no ECHA harmonised H361/H360, no CIR/SCCS opinion). Topical oligopeptides are expected to have minimal systemic bioavailability; no evidence was found that they concentrate in milk or pose a hazard to breastfeeding infants.
- oligopeptide-17 est-il sûr pour la peau de bébé ?
- Hazard and mechanism: no specific reproductive/developmental/infant toxicity data identified (h=0, m=0). Exposure: increased to 1 for infants (0–3 yr) because immature skin barrier and higher surface‑area‑to‑weight can raise per‑kg exposure even for ingredients with low adult absorption; no data were found demonstrating significant dermal absorption for oligopeptide‑17 to justify higher exposure scoring.
- Comment VeriMom évalue-t-il oligopeptide-17 ?
- VeriMom évalue oligopeptide-17 à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à oligopeptide-17 pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à oligopeptide-17 basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.